Nanoprobes to guide cancer radiotherapy dosing

Surface-enhanced Raman scattering (SERS) can help optimise radiotherapy treatment regimes for prostate cancer, UK scientists have shown.

Prostate cancer is the second most common cancer worldwide in men, and the fourth most common cancer overall. It is usually treated with radiotherapy, and doctors would like to tailor doses for individual patients. This would help maximise tumour cell destruction, while minimising damage to normal tissue.

To read the full article by Sarah Rogers, please visit Chemistry World.

Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors

Victoria L. Camus, Grant Stewart, William H. Nailon, Duncan B. McLarend and Colin J. Campbell
Analyst, 2016
DOI:  10.1039/C6AN01032F

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

One Response to “Nanoprobes to guide cancer radiotherapy dosing”

  1. […] sure you also check out out the Chemistry World article on a paper published in this themed issue by Colin Campbell et al. on nanoprobes to guide cancer […]

Leave a Reply

You must be logged in to post a comment.